Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No.
Finazzi
Guido
G
Servizio di Immunoematologia e Medicina Trasfusionale e Centro Emostasi, Ospedali Riuniti di Bergamo, Largo Barozzi 1, 24128, Bergamo, Italy. gfinazzi@ospedaliriuniti.bergamo.it
D017152:Antibodies, Antiphospholipid / Q000097:blood*; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D001241:Aspirin; D002986:Clinical Trials as Topic; D000075202:Contraindications; D005343:Fibrinolytic Agents; D006801:Humans; D011322:Primary Prevention; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D017152:Antibodies, Antiphospholipid; D005343:Fibrinolytic Agents; D001241:Aspirin